Haploidentical stem cell transplantation in patients aged 50 yr and older with leukemia: similar outcomes compared to younger adults
Author:
Affiliation:
1. Peking University People's Hospital; Peking University Institute of Hematology; Beijing China
2. Peking-Tsinghua Center for Life Sciences, Beijing, China
Funder
Bejing Municipal Science & Technology Commission
Publisher
Wiley
Subject
Transplantation
Reference34 articles.
1. Pasquini MC Wang Z Current use and outcome of hematopoietic stem cell transplantation: CIBMTR Summary Slides, 2013 http://www.cibmtr.org
2. Outcome after allogeneic bone marrow transplant for leukemia in older adults;Ringdén;JAMA,1993
3. Allogeneic and syngeneic marrow transplantation for myelodysplastic syndrome in patients 55 to 66 years of age;Deeg;Blood,2000
4. Outcomes in patients age 70 or older undergoing allogeneic hematopoietic stem cell transplantation for hematologic malignancies;Brunner;Biol Blood Marrow Transplant,2013
5. Haploidentical hematopoietic stem cell transplantation with a megadose T-cell-depleted graft: harnessing natural and adaptive immunity;Aversa;Semin Oncol,2012
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Haploidentical hematopoietic stem cell transplantation for patients with myeloid sarcoma: a single center retrospective study;Annals of Hematology;2021-01-08
2. Allogeneic hematopoietic stem cell transplantation for intermediate-risk acute myeloid leukemia in the first remission: outcomes using haploidentical donors are similar to those using matched siblings;Annals of Hematology;2021-01-07
3. Myeloablative Haploidentical Transplantation Is Superior to Chemotherapy for Patients with Intermediate-risk Acute Myelogenous Leukemia in First Complete Remission;Clinical Cancer Research;2018-11-26
4. The role of collateral related donors in haploidentical hematopoietic stem cell transplantation;Science Bulletin;2018-10
5. Everyone has a donor: contribution of the Chinese experience to global practice of haploidentical hematopoietic stem cell transplantation;Frontiers of Medicine;2018-04-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3